# Licensing Outreach Templates

**Date:** 2025-11-15
**Purpose:** Email templates for commercial licensing inquiries
**Status:** Ready to send

---

## Overview

Based on legal assessment, both StatPearls and Medscape require commercial licensing agreements for use in our clinical decision support system. These templates provide professional inquiries to initiate discussions.

---

## Email 1: StatPearls Publishing LLC

**To:** business@statpearls.com (verify current contact)
**CC:** [Your legal/business development contact if applicable]
**Subject:** Commercial Licensing Inquiry for Clinical Decision Support System

```
Dear StatPearls Publishing Team,

I am writing to inquire about commercial licensing opportunities for incorporating
StatPearls content into a clinical decision support system we are developing.

PROJECT OVERVIEW:
We are building an AI-powered clinical decision support platform specifically
designed for infectious disease diagnosis. Our system combines:
- Machine learning-based predictive diagnostic models
- LLM-powered conversational AI for clinical guidance
- Evidence-based knowledge retrieval for clinicians

The platform is intended for use by clinicians in infectious disease clinics,
hospitals, and healthcare systems to assist with diagnostic decision-making,
test selection, and treatment planning.

STATPEARLS VALUE:
We have identified StatPearls as an ideal content source due to:
- Comprehensive, peer-reviewed clinical information
- Excellent infectious disease coverage
- Regular updates by medical experts
- High-quality, structured clinical summaries
- Strong reputation in medical education

CURRENT UNDERSTANDING:
We are aware that StatPearls content is available via NCBI Bookshelf under the
CC BY-NC-ND 4.0 license, which restricts commercial use. We are therefore seeking
a separate commercial licensing agreement.

DISCUSSION TOPICS:
We would like to discuss:
1. Commercial licensing options for incorporating StatPearls content into our
   clinical decision support system
2. Programmatic data access methods (API, bulk download, or data export)
3. Licensing structure and pricing for our use case
4. Content update frequency and maintenance
5. Attribution requirements and quality assurance processes

TECHNICAL REQUIREMENTS:
- Content access: Programmatic via API or structured data export (XML/JSON preferred)
- Update frequency: Monthly or quarterly updates would be ideal
- Coverage needed: Comprehensive infectious disease content

TIMELINE:
We are currently in the data collection phase of development (Phase 2 of 6) and
would like to establish a licensing agreement within the next 1-3 months if terms
are favorable.

Could we schedule a call or meeting to discuss commercial licensing arrangements?
We are flexible on timing and happy to provide additional information about our
project and use case.

Thank you for your consideration. We look forward to the possibility of partnering
with StatPearls to bring high-quality clinical content to our platform.

Best regards,

[Your Name]
[Your Title]
[Company/Organization Name]
[Email]
[Phone]
[Website/LinkedIn if applicable]
```

---

## Email 2: WebMD LLC (Medscape)

**To:** businessdevelopment@webmd.net (verify current contact)
**Alternative:** medscapepartners@webmd.net
**Subject:** Commercial Content Licensing Inquiry for Clinical Decision Support Platform

```
Dear WebMD/Medscape Business Development Team,

I am reaching out to explore commercial content licensing opportunities for
incorporating Medscape clinical reference content into a healthcare technology
platform we are developing.

PROJECT OVERVIEW:
We are building a specialized clinical decision support system for infectious
disease diagnosis that combines artificial intelligence with evidence-based
medical knowledge. Our platform includes:
- Predictive ML models for infectious disease diagnosis
- Conversational AI chatbot for clinical guidance
- Comprehensive knowledge base for evidence retrieval

The system is designed to assist clinicians in infectious disease clinics,
emergency departments, and hospital settings with diagnostic workflows,
test ordering, and treatment planning.

MEDSCAPE VALUE PROPOSITION:
Medscape's clinical reference database is uniquely suited for our application due to:
- Comprehensive disease and condition coverage (6,300+ articles)
- Point-of-care clinical focus
- Extensive drug information (2,100+ monographs)
- Rich multimedia content (30,000+ images/videos)
- Regular updates and physician-reviewed content
- Trusted brand in clinical decision support

COMMERCIAL LICENSING NEED:
We understand that Medscape's terms of use prohibit automated access and commercial
use without explicit written consent. We are therefore seeking to establish a
formal commercial licensing agreement.

DISCUSSION AREAS:
We would like to explore:
1. Commercial content licensing for integration into our clinical software platform
2. Programmatic data access mechanisms (API, structured data feeds, or bulk export)
3. Licensing terms, pricing models, and contract structure
4. Content scope (diseases, drugs, procedures, images)
5. Update frequency and content synchronization
6. Attribution, branding, and quality assurance requirements

TECHNICAL INTEGRATION:
Our ideal integration would include:
- Structured data access (API or data export in JSON/XML)
- Automated content updates (monthly or as-published)
- Full-text articles, drug monographs, and clinical images
- Metadata for categorization and search

BUSINESS MODEL:
Our platform will be offered as a subscription-based SaaS product to healthcare
institutions, with pricing tiers based on organizational size. We anticipate
significant value from incorporating Medscape's authoritative clinical content
and are prepared to discuss revenue sharing or licensing fee structures.

TIMELINE:
We are currently in active development (Phase 2 of a 12-18 month roadmap) and
would benefit from establishing a content partnership within the next 2-6 months.
However, we understand that content licensing agreements of this nature may require
more extended timelines and are committed to working through the necessary processes.

NEXT STEPS:
We would greatly appreciate the opportunity to discuss this potential partnership
in more detail. Could we schedule a call or meeting with the appropriate business
development or partnerships team member?

We are happy to provide additional information about our company, platform
architecture, security measures, compliance frameworks (HIPAA), target market,
and business projections.

Thank you for considering this inquiry. We believe there is strong potential for
a mutually beneficial partnership that would bring Medscape's excellent clinical
content to innovative AI-powered healthcare solutions.

Best regards,

[Your Name]
[Your Title]
[Company/Organization Name]
[Email]
[Phone]
[Website/LinkedIn]
[Company Registration/Legal Entity Information if available]
```

---

## Email 3: Alternative - Academic/Research Partnership Inquiry

**Use this approach if commercial licensing proves cost-prohibitive**

**To:** StatPearls or Medscape contacts
**Subject:** Research Partnership Inquiry for Clinical Decision Support Development

```
Dear [Company] Team,

I am writing to explore potential research partnership or academic collaboration
opportunities for a clinical decision support system development project.

PROJECT CONTEXT:
We are developing an AI-powered diagnostic support tool for infectious diseases
as part of a research and development initiative. The project aims to:
- Advance clinical AI applications in infectious disease diagnosis
- Evaluate machine learning approaches for diagnostic prediction
- Develop conversational AI for clinical knowledge access

RESEARCH PARTNERSHIP PROPOSAL:
Rather than a traditional commercial license, we would like to explore whether
[Company] offers research partnerships or academic collaboration programs that might
provide:
1. Access to content for research and development purposes
2. Collaboration on evaluating AI applications in clinical settings
3. Potential co-publication opportunities on findings
4. Future commercial licensing discussions based on research outcomes

POTENTIAL VALUE TO [COMPANY]:
This partnership could provide:
- Insights into how AI and LLMs can enhance clinical content accessibility
- Research data on clinical knowledge retrieval patterns
- Potential new product development opportunities
- Co-branded research publications
- Feedback on content utility in AI-powered applications

We are open to various partnership structures and would be happy to discuss
what might work best for both parties.

Would you be open to a conversation about research collaboration opportunities?

Best regards,

[Your Name]
[Your Title/Affiliation]
[Contact Information]
```

---

## Email 4: Follow-Up Template (2-3 weeks after initial contact)

**Subject:** Re: Commercial Licensing Inquiry for Clinical Decision Support System

```
Dear [Contact Name],

I wanted to follow up on my email from [Date] regarding commercial licensing
opportunities for [StatPearls/Medscape] content.

I understand that evaluating partnership inquiries requires time and internal
discussion. I'm happy to provide any additional information that would be helpful
for your review process, including:
- Detailed technical specifications for content integration
- Information about our company and team
- Business projections and market analysis
- Security and compliance documentation (HIPAA, SOC 2, etc.)
- Proposed licensing terms for discussion

Is there someone specific in your organization I should connect with regarding
content licensing and business partnerships? Or is there additional information
I can provide to help move this conversation forward?

I remain very interested in exploring a partnership and appreciate your consideration.

Best regards,

[Your Name]
[Contact Information]
```

---

## Sending Strategy and Timeline

### Week 1-2: Preparation
- Finalize company information and business case
- Prepare supporting materials (pitch deck, technical overview)
- Research current contact information
- Legal review of outreach materials (optional but recommended)

### Week 3: Initial Outreach
- Send Email 1 to StatPearls Publishing
- Send Email 2 to WebMD/Medscape Business Development
- Log outreach in CRM or tracking system

### Week 5-6: Follow-Up
- Send Email 4 follow-up if no response
- Attempt to identify specific contacts via LinkedIn or company directory
- Consider phone follow-up if email unresponsive

### Week 8+: Alternative Approaches
- Consider Email 3 (research partnership) if commercial licensing unfeasible
- Explore other content providers if both StatPearls and Medscape decline
- Reassess budget allocation for content licensing

---

## Key Contacts to Research

### StatPearls Publishing LLC
- **Primary:** business@statpearls.com
- **Alternative:** Contact form at statpearls.com
- **Parent Company:** StatPearls Publishing (independently owned)
- **LinkedIn:** Search for "StatPearls Publishing" employees in business development

### WebMD LLC (Medscape Parent)
- **Primary:** businessdevelopment@webmd.net
- **Alternative:** Corporate partnerships contact form
- **Parent Company:** Internet Brands (owned by KKR)
- **LinkedIn:** Search for WebMD or Medscape business development/partnerships roles

---

## Supporting Materials to Prepare

### 1. One-Page Company Overview
- Company name and legal entity
- Mission and vision
- Team background (especially medical/clinical expertise)
- Current stage and funding (if applicable)

### 2. Product Overview (1-2 pages)
- Problem statement
- Solution description
- Technical approach (high-level)
- Target market and users
- Differentiation vs. competitors

### 3. Technical Integration Specification
- Desired content types
- Data format requirements
- Update frequency needs
- Integration architecture
- Security and compliance measures

### 4. Business Case (for internal use)
- Content licensing budget range
- Expected ROI from licensing vs. using free sources
- Strategic value of premium content
- Competitive positioning implications

---

## Expected Outcomes and Contingencies

### Scenario 1: Positive Response (Best Case)
- Licensing negotiations proceed
- Timeline: 1-3 months to agreement
- Budget: $10K-$100K+/year (estimated)
- **Action:** Negotiate favorable terms, include in Phase 3+

### Scenario 2: No Response or Decline (Likely)
- Companies may not respond or may decline
- **Action:** Proceed with open sources (PubMed/PMC, CDC, WHO)
- Revisit after MVP demonstrates value

### Scenario 3: Interested but Expensive (Possible)
- Licensing fees exceed budget
- **Action:** Negotiate deferred payments, revenue sharing, or research partnership
- Consider as future enhancement after revenue generation

### Scenario 4: Research Partnership (Alternative)
- Academic/research collaboration instead of commercial license
- **Action:** Leverage for development phase, transition to commercial later

---

## Decision Matrix

| Response Type | Licensing Cost | Timeline | Action |
|--------------|----------------|----------|--------|
| **Positive, Affordable** | <$25K/year | 1-3 months | ✓ Proceed with licensing, include in Phase 3 |
| **Positive, Moderate** | $25K-$75K/year | 1-3 months | Evaluate ROI, consider for post-MVP |
| **Positive, Expensive** | >$75K/year | 1-6 months | Defer to post-revenue phase |
| **Research Partnership** | Minimal/Free | 2-6 months | ✓ Pursue for R&D phase |
| **No Response/Decline** | N/A | N/A | ✓ Proceed with open sources only |

---

## Success Metrics

**Phase 2 (Current):**
- Emails sent: Week 3
- Responses received: Week 5-8
- Meetings scheduled: Week 6-10

**Phase 3-4 (If Successful):**
- Licensing agreement signed
- Data access established
- Content integrated into knowledge base

**Alternative Success (Open Sources):**
- High-quality knowledge base from PubMed/PMC, CDC, WHO
- Demonstrated clinical utility without premium content
- Strong case for licensing in future

---

## Notes

- Keep all communications professional and concise
- Emphasize mutual benefit and partnership potential
- Be prepared for long sales cycles (3-6+ months typical)
- Have fallback plan (open sources) ready
- Document all communications for legal/compliance
- Consider trademark/IP implications of using "StatPearls" or "Medscape" in marketing

---

**Document Status:** Ready to send
**Next Action:** Finalize company information and send initial outreach
**Owner:** Business Development / Project Lead
